Amit Shard

1.4k total citations
76 papers, 1.1k citations indexed

About

Amit Shard is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Amit Shard has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Organic Chemistry, 33 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Amit Shard's work include Cancer, Hypoxia, and Metabolism (13 papers), Synthesis and Biological Evaluation (11 papers) and Synthesis and biological activity (8 papers). Amit Shard is often cited by papers focused on Cancer, Hypoxia, and Metabolism (13 papers), Synthesis and Biological Evaluation (11 papers) and Synthesis and biological activity (8 papers). Amit Shard collaborates with scholars based in India, United States and Poland. Amit Shard's co-authors include Arun K. Sinha, Sagarkumar Patel, Rajesh Kumar, Naina Sharma, Saima Saima, Rakesh Kumar, Alok Jain, Abhishek Sharma, Richa Richa and Dinkar Sahal and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Scientific Reports.

In The Last Decade

Amit Shard

69 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amit Shard India 21 677 324 101 73 73 76 1.1k
Kirandeep Kaur India 12 790 1.2× 415 1.3× 180 1.8× 58 0.8× 74 1.0× 40 1.3k
María Dolors Pujol Spain 20 952 1.4× 485 1.5× 114 1.1× 58 0.8× 36 0.5× 93 1.3k
Agostino Cilibrizzi United Kingdom 20 325 0.5× 613 1.9× 83 0.8× 141 1.9× 82 1.1× 69 1.1k
Susana D. Lucas Portugal 18 273 0.4× 345 1.1× 77 0.8× 107 1.5× 50 0.7× 40 763
Stephen W. Wright United States 20 978 1.4× 557 1.7× 105 1.0× 92 1.3× 31 0.4× 107 1.6k
Kempegowda Mantelingu India 22 1.1k 1.6× 702 2.2× 54 0.5× 135 1.8× 37 0.5× 110 1.7k
Yiping Qian China 14 387 0.6× 379 1.2× 125 1.2× 98 1.3× 21 0.3× 22 937
Jyoti Agarwal India 17 406 0.6× 576 1.8× 86 0.9× 120 1.6× 84 1.2× 58 1.2k
Brian A. Salvatore United States 20 438 0.6× 487 1.5× 108 1.1× 70 1.0× 19 0.3× 32 1.0k
C. V. Kavitha India 19 660 1.0× 354 1.1× 56 0.6× 99 1.4× 49 0.7× 40 1.0k

Countries citing papers authored by Amit Shard

Since Specialization
Citations

This map shows the geographic impact of Amit Shard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Shard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Shard more than expected).

Fields of papers citing papers by Amit Shard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Shard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Shard. The network helps show where Amit Shard may publish in the future.

Co-authorship network of co-authors of Amit Shard

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Shard. A scholar is included among the top collaborators of Amit Shard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Shard. Amit Shard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jain, Amita, et al.. (2025). Carbohydrate kinase inhibition: a promising strategy in cancer treatment. Drug Discovery Today. 30(2). 104308–104308. 1 indexed citations
3.
4.
Kumar, Hemant, et al.. (2024). Rare diseases and pyruvate kinase M2: a promising therapeutic connection. Drug Discovery Today. 29(5). 103949–103949. 2 indexed citations
5.
Patel, Sagarkumar, et al.. (2024). Design and synthesis of novel quinazolinone-based pyruvate kinase M2 activators as selective inhibitors of oral cancer cells. Journal of Molecular Structure. 1304. 137595–137595. 4 indexed citations
6.
Srivastava, Akshay, et al.. (2024). Modulation of tumour pyruvate kinase M2 and suppression of cancer cell proliferation using natural and synthetic antioxidants. Journal of Molecular Structure. 1305. 137751–137751. 4 indexed citations
7.
Shard, Amit, et al.. (2024). Novel sulfonamides unveiled as potent anti-lung cancer agents via tumor pyruvate kinase M2 activation. RSC Medicinal Chemistry. 15(9). 3070–3091. 2 indexed citations
8.
Behera, Santosh Kumar, et al.. (2024). Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 67(5). 3339–3357. 13 indexed citations
9.
Shard, Amit, et al.. (2024). Modulation of the LIMK Pathway by Myricetin: A Protective Strategy Against Neurological Impairments in Spinal Cord Injury. Neurospine. 21(3). 878–889. 3 indexed citations
10.
Shard, Amit, et al.. (2024). Oxidation states in metallocenes: A key mechanistic component in cancer alleviation. Coordination Chemistry Reviews. 504. 215666–215666. 6 indexed citations
11.
Shard, Amit, et al.. (2023). Comprehensive characterization and preclinical assessment of an imidazopyridine‐based anticancer lead molecule. Drug Development Research. 85(1). e22139–e22139. 3 indexed citations
12.
Choppadandi, Mounika, K. Srinivasa Rao, K. H. Rao, et al.. (2022). Self-regulated cobalt zinc ferrite system as a potential nanoplatform for the synergistic effect of hyperthermia-chemo agent for cancer therapy. Colloids and Surfaces B Biointerfaces. 222. 113077–113077. 10 indexed citations
14.
Shard, Amit, et al.. (2021). A molecular perspective for the use of type IV tyrosine kinase inhibitors as anticancer therapeutics. Drug Discovery Today. 27(3). 808–821. 7 indexed citations
15.
Behera, Santosh Kumar, et al.. (2021). Computational drug repurposing study elucidating simultaneous inhibition of entry and replication of novel corona virus by Grazoprevir. Scientific Reports. 11(1). 7307–7307. 37 indexed citations
16.
Patel, Sagarkumar, Rahul Maheshwari, Akshay Srivastava, et al.. (2021). Discovery of boronic acid-based potent activators of tumor pyruvate kinase M2 and development of gastroretentive nanoformulation for oral dosing. Bioorganic & Medicinal Chemistry Letters. 42. 128062–128062. 14 indexed citations
17.
Kumar, Rajesh, et al.. (2014). Thiol–Ene “Click” Reaction Triggered by Neutral Ionic Liquid: The “Ambiphilic” Character of [hmim]Br in the Regioselective Nucleophilic Hydrothiolation. Angewandte Chemie International Edition. 54(3). 828–832. 60 indexed citations
18.
Kumar, Rakesh, et al.. (2012). Palladium‐Catalyzed Dehydrative Heck Olefination of Secondary Aryl Alcohols in Ionic Liquids: Towards a Waste‐Free Strategy for Tandem Synthesis of Stilbenoids. Angewandte Chemie International Edition. 51(11). 2636–2639. 33 indexed citations
20.
Sinha, Arun K., Naina Sharma, Amit Shard, et al.. (2009). Green methodologies in synthesis and natural product chemistry of phenolic compounds. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 48(12). 1771–1779. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026